Literature DB >> 19728009

A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff.

Noriko Oza1, Yuichiro Eguchi, Toshihiko Mizuta, Eriko Ishibashi, Yoichiro Kitajima, Hiroko Horie, Michiko Ushirogawa, Takeko Tsuzura, Shunya Nakashita, Hirokazu Takahashi, Yasunori Kawaguchi, Yasutomo Oda, Ryuichi Iwakiri, Iwata Ozaki, Takahisa Eguchi, Naofumi Ono, Kazuma Fujimoto.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of the metabolic syndrome. The aim of this study was to evaluate a 6-month home-based lifestyle modification intervention delivered in collaboration with physicians, hygienists, registered dietitians, and nurses.
METHODS: Outpatients with NAFLD diagnosed by abdominal ultrasonography were eligible for this study. Abdominal computed tomography (CT) scan evaluated liver fat deposition by the liver-spleen ratio (L/S ratio) and visceral fat accumulation as the visceral fat area (VFA; cm(2)). During the 6-month home-based lifestyle modification intervention, each patient was examined by physicians, nurses, hygienists, and registered dietitians, who provided individualized advice to the patients. Patients recorded their daily weight for self-control of weight with recommended diet and exercise regimens.
RESULTS: Sixty-seven NAFLD patients were enrolled in this study and 22 patients (32.8%) completed the 6-month intervention. Nineteen of the 22 patients achieved significant improvements in body weight, body mass index (BMI), waist circumference, VFA, L/S ratio, and systolic blood pressure, with improved laboratory data. Overall, 39 patients withdrew from the intervention. The mean age of the patients who withdrew was 50.0 +/- 11.0 years, which was significantly younger than that of the patients who were followed up (60.1 +/- 10.1 years; P < 0.01).
CONCLUSIONS: The reduction in body weight achieved by NAFLD patients during the 6-month intervention was associated with improved fat deposition and liver function. This intervention offers a practical approach for treating a large number of NAFLD patients with lifestyle modification therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19728009     DOI: 10.1007/s00535-009-0115-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

2.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

3.  Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

Authors:  Ayako Suzuki; Keith Lindor; Jenny St Saver; James Lymp; Flavia Mendes; Ayako Muto; Toshihide Okada; Paul Angulo
Journal:  J Hepatol       Date:  2005-07-11       Impact factor: 25.083

Review 4.  Natural history of NAFLD: remarkably benign in the absence of cirrhosis.

Authors:  C P Day
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

5.  Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients.

Authors:  Yoshifumi Tamura; Yasushi Tanaka; Fumihiko Sato; Jong Bock Choi; Hirotaka Watada; Masataka Niwa; Junichiro Kinoshita; Aiko Ooka; Naoki Kumashiro; Yasuhiro Igarashi; Shinsuke Kyogoku; Tadayuki Maehara; Masahiko Kawasumi; Takahisa Hirose; Ryuzo Kawamori
Journal:  J Clin Endocrinol Metab       Date:  2005-03-15       Impact factor: 5.958

6.  Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance.

Authors:  D A de Luis; R Aller; O Izaola; M Gonzalez Sagrado; R Conde; J M Gonzalez
Journal:  Diabetes Res Clin Pract       Date:  2007-09-04       Impact factor: 5.602

7.  Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study.

Authors:  P Riley; D Sudarshi; M Johal; A Benedict; J Panteli; M Crook; J O'Donohue
Journal:  Int J Clin Pract       Date:  2008-01-14       Impact factor: 2.503

8.  A randomized trial of a low-carbohydrate diet for obesity.

Authors:  Gary D Foster; Holly R Wyatt; James O Hill; Brian G McGuckin; Carrie Brill; B Selma Mohammed; Philippe O Szapary; Daniel J Rader; Joel S Edman; Samuel Klein
Journal:  N Engl J Med       Date:  2003-05-22       Impact factor: 91.245

9.  Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females.

Authors:  Eriko Ishibashi; Yuichiro Eguchi; Takahisa Eguchi; Aki Matsunobu; Noriko Oza; Shunya Nakashita; Yoichiro Kitajima; Shigetaka Kuroki; Iwata Ozaki; Yasunori Kawaguchi; Yasushi Ide; Tsutomu Yasutake; Ryuichi Iwakiri; Toshihiko Mizuta; Naofumi Ono; Kazuma Fujimoto
Journal:  J Gastroenterol Hepatol       Date:  2008-03-27       Impact factor: 4.029

Review 10.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.

Authors:  Clare L Gillies; Keith R Abrams; Paul C Lambert; Nicola J Cooper; Alex J Sutton; Ron T Hsu; Kamlesh Khunti
Journal:  BMJ       Date:  2007-01-19
View more
  31 in total

1.  Oral Recombinant Methioninase Prevents Nonalcoholic Fatty Liver Disease in Mice on a High Fat Diet.

Authors:  Yoshihiko Tashiro; Qinghong Han; Yuying Tan; Norihiko Sugisawa; Jun Yamamoto; Hiroto Nishino; Sachiko Inubushi; Y U Sun; Hyein Lim; Takeshi Aoki; Masahiko Murakami; Yoshihisa Takahashi; Michael Bouvet; Robert M Hoffman
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Toshihiko Mizuta; Yoshio Sumida; Eriko Ishibashi; Yoichiro Kitajima; Hiroshi Isoda; Hiroko Horie; Takaya Tashiro; Eri Iwamoto; Hirokazu Takahashi; Takuya Kuwashiro; Shu Soejima; Yasunori Kawaguchi; Yasutomo Oda; Sei Emura; Ryuichi Iwakiri; Iwata Ozaki; Takahisa Eguchi; Naofumi Ono; Keizo Anzai; Kazuma Fujimoto; Shunzo Koizumi
Journal:  J Gastroenterol       Date:  2010-11-02       Impact factor: 7.527

Review 3.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

4.  Reply to the letter by Lai et al. regarding "body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal study".

Authors:  Teruki Miyake; Teru Kumagi; Shinya Furukawa; Masanori Abe; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2013-01-30       Impact factor: 7.527

5.  Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan; Erik P Kirk; Bettina Mittendorfer; Bruce W Patterson; Samuel Klein
Journal:  Hepatology       Date:  2012-04-25       Impact factor: 17.425

6.  Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study.

Authors:  Takumi Kawaguchi; Naoto Shiba; Takashi Maeda; Toru Matsugaki; Yoshio Takano; Minoru Itou; Masahiro Sakata; Eitaro Taniguchi; Kensei Nagata; Michio Sata
Journal:  J Gastroenterol       Date:  2011-02-22       Impact factor: 7.527

7.  Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses.

Authors:  Yoshiko Fukuyama; Daisuke Tokuhara; Shinichi Sekine; Kosuke Kataoka; Jonathan D Markham; Allyson R Irwin; Grace H Moon; Yuka Tokuhara; Keiko Fujihashi; Julia Davydova; Masato Yamamoto; Rebekah S Gilbert; Kohtaro Fujihashi
Journal:  Biochem Biophys Res Commun       Date:  2011-12-19       Impact factor: 3.575

Review 8.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

Review 9.  The use of lorcaserin in the management of obesity: a critical appraisal.

Authors:  Bo Bai; Yu Wang
Journal:  Drug Des Devel Ther       Date:  2010-12-20       Impact factor: 4.162

Review 10.  Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Authors:  Shira Zelber-Sagi; Justyna Godos; Federico Salomone
Journal:  Therap Adv Gastroenterol       Date:  2016-03-17       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.